Cinven pops latest €7bn fund for $1.4bn Bioclinica acquisition

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
LevFin
LevFin Leveraged Loans

Cinven pops latest €7bn fund for $1.4bn Bioclinica acquisition

Max Bower
August 23, 2016 02:45 pm
biopharma

Cinven has made the first acquisition from its latest €7bn European focused fund for US healthcare firm Bioclinica.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Syndicated LoansLoans and High YieldLevFinLeveraged LoansLevFin Leveraged LoansEuropeEMEAPrivate Equity
MB
Max Bower
Gift this article